Medical devices industry venture financing deals in February 2020 total $1.01bn globally

23 March 2020 (Last Updated March 23rd, 2020 14:18)

Medical devices industry venture financing deals in February 2020 total $1.01bn globally

Total medical devices industry venture financing deals in February 2020 worth $1.01bn were announced globally, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked a decrease of 8.3% over the previous month and a rise of 14.6% when compared with the last 12-month average, which stood at $883.36m.

Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $779.78m. At the country level, the US topped the list in terms of deal value at $760.99m.

In terms of volumes, North America emerged as the top region for medical devices industry venture financing deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of venture financing deals activity in February 2020 was the US with 53 deals, followed by China with five and France with four.

In 2020, as of the end of February 2020, medical devices venture financing deals worth $2.12bn were announced globally, marking an increase of 21.1% year on year.

Medical devices industry venture financing deals in February 2020: Top deals

The top five medical devices industry venture financing deals accounted for 50% of the overall value during February 2020.

The combined value of the top five medical devices venture financing deals stood at $505.68m, against the overall value of $1.01bn recorded for the month.

The top five medical devices industry deals of February 2020 tracked by GlobalData were:

1) General Catalyst Partners, HBM Healthcare Investments, Khosla Ventures, Lightspeed Management Company and SoftBank Vision Fund’s $165m venture financing of Karius

2) The $125m venture financing of Outset Medical by D1 Capital Partners, Fidelity Management & Research, Partner Fund Management, Perceptive Advisors and T. Rowe Price Group

3) 11.2 Capital, Atomico Ventures, Bessemer Venture Partners, Heuristic Capital Partners Management Co, Insight Partners, Lead Edge Capital Management and Quadrille Capital’s $90m venture financing of Hinge Health

4) The $85.68m venture financing of Universal Medical Imaging Group by Cathay Capital Private Equity, CEC Capital, GT Capital Holdings, Tianjin Hidea Investment Management, Tianjin Teda and V Star Capital

5) Andreessen Horowitz’s venture financing of Q Bio for $40m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.